AAIPharma appoints new COO
This article was originally published in Scrip
The US-based company AAIPharma has appointed Scott Neilsonchief operating officer. Mr Neilson, who has worked with MDS Pharma Services, LabCorp, Covance and SmithKline Beecham, will be responsible for AAIPharma's global drug development services operations. The company provides product development and support services to the pharmaceutical, biotech and medical device industries.
You may also be interested in...
While information sharing is key to cross-country collaborations on access to medicines and can lead to major benefits, it is hard to sell to political leaders and the media, says a report from the World Health Organization’s regional office for Europe.
The European Commission says it will publish its review of the EU orphan drug legislation in the coming days.
The UK has formally withdrawn its ratification of the Unified Patent Court Agreement, adding to the uncertainty over its future.